Editorial Standards · Updated April 2026

Editorial Policy

ClearMetabolic publishes information about GLP-1 medications, weight-loss programs, and metabolic health. Because this is a health topic where decisions affect real outcomes and budgets, every page on this site follows the standards below.

Who Writes This Site

Most articles are written by Ash Heleka, the founder of ClearMetabolic. Ash has been on Mounjaro (tirzepatide) since 2024 and tracks progress with DEXA scans every 8 to 12 weeks. He is not a clinician. His background is in investment banking and management consulting. The site's reporting strength is data analysis, pricing transparency, and lived experience, not medical advice.

Where lived experience or business analysis is the angle, Ash writes in first person. Where the topic requires medical claims (dosing, side effects, contraindications, drug interactions), the article cites the relevant clinical trial, FDA label, or peer-reviewed source.

Sourcing Standards

Every claim about clinical efficacy, safety, or dosing is sourced from one of the following primary sources:

• FDA-approved drug labels and prescribing information
• Phase 3 clinical trials (SURPASS, SURMOUNT, STEP, SELECT, etc.)
• Peer-reviewed publications indexed in PubMed
• FDA shortage list and FDA newsroom announcements
• Manufacturer published statements (Eli Lilly, Novo Nordisk, etc.)
• State and federal pharmacy regulatory bodies (NABP, state boards of pharmacy)

Pricing claims are sourced from each provider's published cash-pay pricing page and re-verified monthly via the GLP-1 Cash-Pay Pricing Index methodology.

Fact-Checking and Review

Every guide and review goes through a single editorial pass before publishing that checks for factual accuracy, source linking, and date stamps. We re-verify pricing data on the first of every month and refresh year-stamped pages annually. Pages that report on time-sensitive topics (FDA shortages, payer coverage, manufacturer pricing) are reviewed quarterly at minimum.

If you find an error on any page, please email hello@clearmetabolic.com. Confirmed factual errors are corrected within 7 days and logged in our corrections record.

Conflict of Interest and Affiliate Disclosure

ClearMetabolic earns affiliate commissions when readers click through to providers and sign up for paid programs. Affiliate relationships do not affect editorial rankings, ClearScore calculation, or which providers we cover. Several providers we recommend at the top of our rankings have no affiliate relationship with the site. Several providers with affiliate relationships are not recommended.

We do not accept payment for placement, paid reviews, or sponsored content. We do not write reviews of products we have not researched independently. Providers cannot pay to be listed in the directory or to improve their ClearScore.

For full affiliate disclosure see our disclaimer page.

What This Site Does Not Do

• We do not provide medical advice, diagnosis, or treatment recommendations.
• We do not prescribe medications.
• We do not handle pharmacy operations or fulfill prescriptions.
• We do not have a financial relationship with Eli Lilly, Novo Nordisk, or any manufacturer.
• We do not republish content generated by AI models without human review and editing.

How to Reach Us

For corrections, fact-check requests, data inquiries, or methodology questions, email hello@clearmetabolic.com. For provider listing claims and updates, use the claim form on the relevant provider page.